QLYSQualys, Inc.
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $1.67Beat
- vs $1.46 expected on Nov 9
- Stock move on it
- −13.51%
- one session
- Typical move
- ±13.6%
- average over 2 reports
- Price
- $172.50
- −5.58% today
Past and upcoming reports
2
| Nov 9, 2026 | Sep 30, 2026 | After the market closes | $1.46 | Beat$1.67 | −13.51% |
| Aug 4, 2026 | Jun 30, 2026 | Time not given | $1.78 | not recorded | +13.78% |
After the report
Nov 9, 2026 report
Qualys rallied 6.32% after the reported print, but absent EPS and guidance data leave the thesis only partially confirmed
Qualys closed at $202.45, up $12.04 on November 9, while reported EPS, revenue, and explicit guidance remained unavailable. valuation and growth expectations remain key risks.
Reported against expected
Reported EPS and revenue were not captured, so no beat or miss can be confirmed. the pre-print EPS estimate was $1.46.
Guidance
Explicit management guidance was not available. post-results forecast updates were identified as the next catalyst.
How the stock reacted
QLYS rose 6.32% to $202.45 on November 9, trading between $190.70 and $204.75 on 983,237 shares.
What changed
QLYS rose 6.32% to $202.45, but reported EPS, revenue, and guidance remained uncaptured after the November 9 print.
What the price now assumes
The rally suggests constructive near-term interpretation despite 23.71x forward P/E versus the sector’s 17.33x.
What it means for the business
Keep a constructive-but-unconfirmed bias. upgrade only if forecast updates support 8.14% next-year EPS growth.
The next one to three months, as we saw it then
Better case35%
The post-results rally extends if forecast updates validate continued earnings expansion despite the premium multiple.
Base case45%
The stock consolidates near the $202.67 analyst target as strong profitability offsets only moderate growth.
Worse case20%
A growth slowdown pressures the premium valuation, consistent with TTM revenue growth of 10.35% versus the sector’s 22.94% benchmark.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.